Current visiting times

After suspending visiting earlier in the year, we are now able to offer limited visiting to some wards at the discretion of the nurse in-charge.”

Read more on visiting times...


Messages for loved ones and keeping in touch

We recognise the impact that a long stay in hospital can have on families and the importance of maintaining strong communication.  Our ward staff are keeping in touch with patients’ next of kin directly and our Patient Advice and Liaison Service (PALS) can help pass on personal messages from family and friends.

Read more information about messages for loved ones…

Current visiting times

After suspending visiting earlier in the year, we are now able to offer limited visiting to some wards at the discretion of the nurse in-charge.”

Read more on visiting times...


Messages for loved ones and keeping in touch

We recognise the impact that a long stay in hospital can have on families and the importance of maintaining strong communication.  Our ward staff are keeping in touch with patients’ next of kin directly and our Patient Advice and Liaison Service (PALS) can help pass on personal messages from family and friends.

Read more information about messages for loved ones…

During your stay in hospital you will meet a number of different members of staff.  All members of staff wear name badges, but if you are not sure who someone is or what they do, please feel free to ask them to introduce themselves and explain what they do. 

If you have any questions about your treatment, please ask a doctor or a nurse.

There are lots of opportunities for you to get involved with the Trust, from volunteering to attending our public meetings, our Annual General Meeting or our hospital open day which is held every year.

Spotlight on our research staff

Last updated: 12 August 2021

Spotlight on Researchers

To celebrate research undertaken by our research staff here at PHU, the research and innovation team brings you 'Spotlight'. Each month we will be highlighting members of our team and putting a spotlight on their achievements and current research including any recent publications.

 

This month's featured spotlight is on clinical research fellow in hepatology, Dr Ben Giles

Dr Ben Giles   Heptology research fellow

Having recently been nominated for, and winning PHU’s junior doctor award for his outstanding contribution to education, research, and improvement, it’s been a whirlwind year for Dr Ben Giles, who joined the Hepatology Department as a clinical research fellow in August 2020.

Increasing rates of liver-related deaths in the UK, a lack of effective treatments in many areas of hepatology, as well as an interest in the specialty, first led to Ben getting involved in hepatology research:

“By gaining this invaluable experience I have been able to see first-hand the direct correlation between research and the positive impact it can have on treatments and patient outcomes.”

Despite the disruptions caused by the pandemic, Ben set up the UK's first national registry for people with Polycystic Liver Disease (PLD) which is currently being expanded to other sites across the UK. Ben’s work has also culminated in PHU becoming the first centre in the UK to complete data collection of over 100 patients in a national Primary Biliary Cholangitis (PBC) audit. In addition, he carried out a controlled evaluation of the impact of the Portsmouth Liver Centre’s nurse-led decompensated cirrhosis service on patient outcomes. This highlighted the huge impact this service has in reducing unplanned hospital re-admissions and deaths in this high-risk patient group.

Over the past year, Ben has conducted a five-year review to evaluate ‘aMAP’, a scoring system to help predict hepatocellular carcinoma (HCC) for patients with cirrhosis - a leading cause of death in patients with chronic viral hepatitis and globally, the fourth most frequent cause of cancer-related death. Ben's study was the first evaluation of aMAP in an unselected UK population, and demonstrated that HCC patients have a "high risk" score up to five years before their presentation with cancer and was recently presented at the national UK-HCC conference.  By identifying this risk in the early stages will potentially allow more focused surveillance of patients at higher risk.

During the second wave of Covid-19, Ben made an enormous contribution to the delivery of urgent Covid-19 therapy trials here in Portsmouth. He also worked on a project looking at the differences in severity of disease in patients with the B.1.1.7 (alpha or ‘Kent’) Covid-19 variant which was recently published.

“It is incredibly rewarding to see how research and collation of data can lead to successfully identifying new treatments for patients. It was a real honour recently to be involved with a particular patient’s discharge from hospital who had Covid-19. Had it not been for her receiving a new treatment for Covid-19 that we researched as part of the Recovery trial here in Portsmouth, she may have required admission to the intensive care unit and quite possibly have died.”

Ben’s links:

Publications: The SARS-CoV-2 B.1.1.7 variant and increased clinical severity-the jury is out.
Twitter: @BenGiles146

Back to top
Working together to drive excellence in care for our patients and communities Page feedback Tell us what you think

Get in touch

Queen Alexandra Hospital,
Cosham,
Portsmouth,
PO6 3LY

© 2021, Portsmouth Hospitals NHS Trust